Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1931 1
1960 1
1970 1
1975 1
1979 1
1988 1
1989 1
1990 1
1992 3
1993 1
1994 3
1996 2
1997 1
2003 1
2004 2
2005 1
2007 1
2008 1
2009 3
2010 1
2011 1
2014 1
2015 3
2017 1
2018 1
2019 3
2020 4
2021 8
2022 4
2023 5
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Abraham JE, Pinilla K, Dayimu A, Grybowicz L, Demiris N, Harvey C, Drewett LM, Lucey R, Fulton A, Roberts AN, Worley JR, Chhabra A, Qian W, Vallier AL, Hardy RM, Chan S, Hickish T, Tripathi D, Venkitaraman R, Persic M, Aslam S, Glassman D, Raj S, Borley A, Braybrooke JP, Sutherland S, Staples E, Scott LC, Davies M, Palmer CA, Moody M, Churn MJ, Newby JC, Mukesh MB, Chakrabarti A, Roylance RR, Schouten PC, Levitt NC, McAdam K, Armstrong AC, Copson ER, McMurtry E, Tischkowitz M, Provenzano E, Earl HM. Abraham JE, et al. Among authors: scott lc. Nature. 2024 May;629(8014):1142-1148. doi: 10.1038/s41586-024-07384-2. Epub 2024 Apr 8. Nature. 2024. PMID: 38588696 Free PMC article. Clinical Trial.
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.
Abraham JE, O'Connor LO, Grybowicz L, Alba KP, Dayimu A, Demiris N, Harvey C, Drewett LM, Lucey R, Fulton A, Roberts AN, Worley JR, Chhabra MA, Qian W, Brown J, Hardy R, Vallier AL, Chan S, Cidon MEU, Sherwin E, Chakrabarti A, Sadler C, Barnes J, Persic M, Smith S, Raj S, Borley A, Braybrooke JP, Staples E, Scott LC, Palmer CA, Moody M, Churn MJ, Pilger D, Zagnoli-Vieira G, Wijnhoven PWG, Mukesh MB, Roylance RR, Schouten PC, Levitt NC, McAdam K, Armstrong AC, Copson ER, McMurtry E, Galbraith S, Tischkowitz M, Provenzano E, O'Connor MJ, Earl HM; PARTNER Trial Group. Abraham JE, et al. Among authors: scott lc. Nat Commun. 2025 May 13;16(1):4269. doi: 10.1038/s41467-025-59151-0. Nat Commun. 2025. PMID: 40360463 Free PMC article. Clinical Trial.
Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia.
Elsherif L, Tang Y, Patillo KL, Wichlan D, Ogu UO, Landes K, McCune P, Scott LC, Gulledge W, Woodland WH, Nelson M, Loehr LR, Cronin RM, Desai PC, Zhou LY, Pollock DM, Zou F, Cai J, Derebail VK, Ataga KI. Elsherif L, et al. Among authors: scott lc. Br J Haematol. 2024 Nov;205(5):1963-1973. doi: 10.1111/bjh.19743. Epub 2024 Sep 3. Br J Haematol. 2024. PMID: 39228027
Improvised strap weight.
Brown A, Scott LC, Fatzinger SH. Brown A, et al. Among authors: scott lc. Phys Ther. 1970 Mar;50(3):361-4. doi: 10.1093/ptj/50.3.361. Phys Ther. 1970. PMID: 5442383 No abstract available.
Ocular melanoma incidence rates and trends in the United States, 2001-2016.
Culp MB, Benard V, Dowling NF, King J, Lu H, Rao C, Scott LC, Wilson R, Wu M. Culp MB, et al. Among authors: scott lc. Eye (Lond). 2021 Feb;35(2):687-689. doi: 10.1038/s41433-020-0885-1. Epub 2020 Apr 29. Eye (Lond). 2021. PMID: 32350449 Free PMC article. No abstract available.
64 results